Disclosures for "Movement Disorders in Antibody-associated Neurological Diseases: A Nationwide Study"
-
Mr. Kerstens has received research support from European Joint Programme on Rare Diseases. The institution of Mr. Kerstens has received research support from Erasmus Trust Fund.
-
Juna De Vries has nothing to disclose.
-
Ms. Brenner has nothing to disclose.
-
Yvette Crijnen has nothing to disclose.
-
The institution of Mr. van Steenhoven has received research support from Autoimmune Encephalitis Alliance . The institution of Mr. van Steenhoven has received research support from Dutch Alzheimer's foundation.
-
Dr. de Bruijn has nothing to disclose.
-
Author has nothing to disclose
-
Dr. van Coevorden has nothing to disclose.
-
Anna Bastiaansen has nothing to disclose.
-
Ms. Vermeiren has nothing to disclose.
-
Rinze F Neuteboom has nothing to disclose.
-
Sharon Veenbergen has nothing to disclose.
-
The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Boon has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. The institution of Dr. Boon has received research support from Erasmus Trust Fonds.
-
The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care.